Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2013 Jun 17:19:467-74.
doi: 10.12659/MSM.883954.

A single center prospective study of bilateral breast reconstruction with free abdominal flaps: a critical analyses of 144 patients

Affiliations
Clinical Trial

A single center prospective study of bilateral breast reconstruction with free abdominal flaps: a critical analyses of 144 patients

Christoph Andree et al. Med Sci Monit. .

Abstract

Background: Bilateral breast reconstruction utilising autologous free tissue transfer is a complex procedure with multiple options for donor tissue available. Autogenous breast reconstruction techniques have evolved over the last three decades to meet this goal. The aim of this study was to determine the outcomes of patients undergoing bilateral breast reconstruction with DIEAP, TRAM or SIEA flaps.

Material and methods: A prospective study was performed in our Interdisciplinary Breast Centre from July 2004 until December 2011 in 144 patients. Demographic information, diabetes mellitus type I status, tobacco use, tumor stage, primary/secondary reconstruction, operative technique, adjuvant therapy received, length of follow-up, and complications were evaluated. Complications were divided into donor site and recipient site. To investigate which risk factors were independently related to flap loss (complete or partial), multiple linear regression analysis was performed.

Results: The study identified 144 patients who had bilateral breast reconstruction with DIEAP, TRAM or SIEA flaps. For all flaps (n=248), outcome included 98.4% survival and 0.7% vein microanastomosis revision. Recipient site complications included 1.6% complete flap loss, 0.8% fat necrosis, 2.9% partial skin loss/dehiscence flap necrosis and 2.0% haematoma rate. Donor site complications included 3.7% partial skin loss/dehiscence. There was evidence of abdominal bulges in TRAM patients (1.1%) but no hernias in any patients. BMI is a major determinant of flap loss (complete or partial) in these patients.

Conclusions: The primary goal of bilateral breast reconstruction is to provide a treatment option that can create a natural, symmetric breast mounds with minimal donor-site morbidity following bilateral mastectomies. These results support weight loss therapy prior to bilateral breast reconstruction.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Perioperative Markings depending on the perioperative Doppler detection.
Figure 2
Figure 2
Selection of Perforators on the left side of the abdomen.
Figure 3
Figure 3
Morbidity of the donor site after bilateral DIEAP flaps. Wide abdominal rectus plication has been performed to achieve better cosmesis.
Figure 4
Figure 4
Closing the abdomen with inserting the belly button in the middle approximately 7–9 cm from the horizontal scar.
Figure 5
Figure 5
(A, B) Bilateral breast cancer, bilateral breast conserving therapy, Radiotherapy both sides. (C, D) 11 days after bilateral Skin sparing mastectomy and reconstruction with DIEAP flaps. Wound healing problems with skin necrosis on the original breast skin and at the abdominal scar. (E, F) One year after surgery with complete healing of the wounds.
Figure 6
Figure 6
Bilateral reconstruction with DIEAP flaps after skin sparing mastectomy.
Figure 7
Figure 7
Bilateral reconstruction with DIEAP flaps after removing the capsular contracture and the implants.

References

    1. Al-Benna S, Steinstraesser L. Postablative reconstruction is better terminology than oncoplastic surgery. Plast Reconstr Surg. 2009;124:463e–64e. - PubMed
    1. Audretsch W, Andree C. Is mastectomy still justified – and if, in which patients? Onkologie. 2006;29:243–45. - PubMed
    1. Al-Benna S, Poggemann K, Steinau HU, Steinstraesser L. Diagnosis and Management of Primary Breast Sarcoma. Breast Cancer Res Treat. 2010;22(3):619–26. - PubMed
    1. Bach AD, Kneser U, Kopp J, Andree C, et al. Possibilities for breast reconstruction following cancer surgery. MMW Fortschr Med. 2004;146:40–42. 44. - PubMed
    1. Al-Benna Female plastic and reconstructive surgeons’ personal decision making for breast cancer treatment and reconstruction. Arch Gynecol Obstet. 2011;284:737–41. - PubMed

Publication types